Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Innovent Announces 2022 Annual Results and Business Updates

Building an Innovative Biopharmaceutical Company with Sustainable Growth and Comprehensive Capability ROCKVILLE, Md. and SUZHOU, China, March 29, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commer...

2023-03-29 08:00 2916

Verbal Beginnings partners with The Clinician to launch a Patient Reported Outcomes Program for Children with Autism Spectrum Disorder

COLUMBIA, Md., March 29, 2023 /PRNewswire/ -- A leading US-based Applied Behavior Analysis (ABA) therapy provider , Verbal Beginnings, has partnered with The Clinician, a global healthcare company, to pilot a patient reported outcome measures (PROMs) program for...

2023-03-29 02:32 1700

AliExpress Signs Product Safety Pledge+ at the European Consumer Summit 2023

Elevating its voluntary commitment on product compliance for a fair, regulated online marketplace BRUSSELS, March 28, 2023 /PRNewswire/ -- AliExpress, a global retail online marketplace part of Alibaba Group, today signed the EU's Product Safety Pledge+, a voluntary commitment facilitated by the...

2023-03-28 22:00 1541

Healthcare Revolution: Medical Tourism and the American Dream

PALM BEACH GARDENS, Fla., March 28, 2023 /PRNewswire/ -- The 15th annual Healthcare Revolution (May 23, 2023), the largest confluence of thought leaders in the world of healthcare, self-funded employers, brokers, and healthcare leaders, has launched, and this time with thought-provoking and insig...

2023-03-28 21:53 1810

Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

SUZHOU, China, March 28, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has completed the enrollment of 740 subjects recently for...

2023-03-28 21:41 1413

Antengene Announces Results for Full Year 2022 with Updates Highlighting a Sales Revenue Reaching 5.6 Times Year-Over-Year and Accelerated Global Innovation

SHANGHAI and HONG KONG, March 28, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), today announced its full-year 2022 financial results and provided updates on key events and achievements since the start of 2022. 1. Sales Revenue Reached 5.6 Times Year-Over-Year ...

2023-03-28 21:40 2206

BIMINI HEALTH TECH ACQUIRES EXCLUSIVE LICENSE TO ACELLULAR DERMAL MATRIX PRODUCT PORTFOLIO

Acquisition expands Bimini's global soft tissue franchise, which already includes the PureGraft and Dermapose Fat Transfer Systems PLANO, Texas, March 28, 2023 /PRNewswire/ -- Bimini Health Tech announced today it has acquired the exclusive rights to an Acellular Dermal Matrix ("ADM") technology...

2023-03-28 21:20 1456

New Study Reveals Clinical Instability Predicts Psychiatric Hospitalization

First study of its kind, based on real-world data from Holmusk's NeuroBlu Database, shows patients who score highest for severity and instability were 45% more likely to be hospitalized NEW YORK, March 28, 2023 /PRNewswire/ -- For patients with psychiatric conditions, illness severity and i...

2023-03-28 21:00 1791

Pulnovo Medical Announces 3-Year Follow-up Results from PADN-5 at THT 2023, The Medical Device Maker Breaks New Ground in Heart Failure Treatment

SHANGHAI, March 28, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform, announced the results from its PADN series study during the Late-Breaking Clinical Science (LBCS) session of the second Technology and Heart Failure Therapeutics (THT 2023), with the presentatio...

2023-03-28 20:30 1442

WuXi Biologics Congratulates Amicus Therapeutics on European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease

WUXI, China, March 28, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates its strategic partner Amicus Therapeutics ("Amicus") (Nasdaq: FOLD) on receiving European Commission's approval ...

2023-03-28 20:11 1921

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

NANJING, China, March 28, 2023 /PRNewswire/ -- PharmaBlock (Stock code: 300725.SZSE), a global, fully integrated CDMO company focusing on innovative chemistry and low-carbon manufacturing, announced today that it has been selected asthe winner of the 2023 CMO Excellence in Green Chemistry Award ...

2023-03-28 20:00 1399

Sirnaomics Announces 2022 Annual Results

Significant Progress in Clinical Trials for Core Products Reinforces Leading Position in RNA Therapeutics with Strong Product Pipeline Matrix Business Highlights * Clinical development * STP705 - The part-one Phase IIb interim data on STP705 for the treatment of isSCC was announced, with th...

2023-03-28 19:26 6445

Tigermed Reports Full Year 2022 Results

HANGZHOU, China, March 28, 2023 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its an...

2023-03-28 19:09 1865

Seegene declares to share Syndromic PCR technologies to prevent future pandemics

* Localization of Seegene Syndromic PCR technologies with global partners for versatile and proactive response to local emerging healthcare demands. * Formation of a collaborative global network to aggressively develop innovative syndromic PCR assays, challenging boundaries of PCR application....

2023-03-28 19:00 1621

Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in Patients with Advanced Solid Tumours

First-in-Class ERAP1 Inhibitor Enters Clinical Development Study to Evaluate GRWD5769 as Monotherapy, as well as in Combination with PD-1 Inhibitor Libtayo® (cemiplimab) OXFORD, UK and MELBOURNE, AUSTRALIA, March 28, 2023 /PRNewswire/ -- Grey Wolf Therapeutics, a biotechnology company focused on...

2023-03-28 19:00 1402

Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement

Performance Highlights: * During the reporting period, the revenue was RMB 43.952 billion, with a year-on-year growth of12.66%; the net profit after deducting extraordinary gain or loss attributable to owners of the parent wasRMB 3.873 billion, with a year-on-year growth of 18.17%; * The rev...

2023-03-28 16:20 2348

Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement

OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab

SHENZHEN, China, March 28, 2023 /PRNewswire/ -- OncoVent Co., Ltd. ("OncoVent"), a majority-controlled subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (the "Company"), yesterday entered into a license agreement with Orient EuroPharma Co., Ltd. ("OEP"). According to the terms of th...

2023-03-28 15:36 1469

Amway Applauded by Frost & Sullivan for Capitalizing on Innovative Competitive Strategies to Drive Differentiation in Its Home Water Treatment Solution in APAC

Amway leverages its extensive R&D capabilities and innovation agility to drive its customer-driven product development strategy. SAN ANTONIO, March 28, 2023 /PRNewswire/ -- Frost & Sullivan recently analyzed the home water treatment (HWT) industry and, based on its assessment results, recognizes...

2023-03-28 13:13 1389

Amway Applauded by Frost & Sullivan for Capitalizing on Innovative Competitive Strategies to Drive Differentiation in Its Home Water Treatment Solution in APAC

Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV

Tavneos® newly introduced in the 2022 European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of ANCA-associated vasculitis (AAV) Recommendations recognize Tavneos®' ability to induce and sustain remission, lower glucocorticoids-induced toxic effects and pot...

2023-03-28 13:00 2074

Acepodia to Present Preclinical Data of Gamma Delta T cell Therapy Candidate, ACE2016, an off-the-shelf EGFR-targeting γδ2 T cell therapy against EGFR-expressing solid tumors

ALAMEDA, Calif. and TAIPEI, March 27, 2023 /PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique antibody-cell conjugation (ACC) technology to address gaps in cancer care, today announced the upcoming poster presentation of new ...

2023-03-28 10:00 1367

1 ... 179 180 181182183 184 185 ... 808